Navigation Links
PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument
Date:10/13/2011

ANNAPOLIS, Md., Oct. 13, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) today announced that it has filed its legal brief in response to SIGA Technologies' motion for reargument.  On September 22, 2011 PharmAthene announced that the Delaware Court of Chancery had issued a ruling in its litigation against SIGA and awarded PharmAthene 50% of the net profits over 10 years from all sales of ST-246 and related products after SIGA receives the first $40 million in net profits.

The defendant's motion for reargument asserts, among other things, that the Court erred in its application of law in awarding an equitable payment stream to PharmAthene.  In its legal brief, PharmAthene outlines specific examples in Delaware case law supporting Vice Chancellor Parson's use of a constructive trust as an appropriate equitable remedy.  

"We look forward to Judge Parson's decision on the motion and next steps," commented Eric I. Richman, President and Chief Executive Officer.  "If the court denies the motion, the parties will have 20 days from that date to submit a proposed form of final judgment, following which the Court will render its final order."

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

In addition,
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
5. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
6. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
7. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
8. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
9. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
10. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
11. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/15/2014)... Ohio , Jan. 15, 2014  A novel wearable injector ... easy and painless for patients to self-inject prescription drugs in ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to grow to $220B by 2018, according to analysts.   Many ...
(Date:1/14/2014)... Brandeis Medical Center, led by Dr. Emmanuel Brandeis , offers ... tattoo removal experience with the advanced Astanza Duality laser and a ... cosmetic services with cutting edge medical technology and offering expert medical ... has seen a dramatic increase in the presence of tattoo ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 2012 On Jan. 23, IUE/CWA Local 81408, the ... Newtown Square eyeglass manufacturing facility, went on strike. This ... (IUE/CWA). Although 115 employees are covered under the bargaining ... According to company officials, each day, additional employees have ...
... Feb. 2, 2012    NorthCrest Medical Center will deploy ... ™ (SCM) acute care Electronic Health Record (EHR) to support ... (Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) ... across every measure of patient care, and Allscripts will help ...
Cached Medicine Technology:Despite Employee Strike, Davis Vision Lab Continues to Fulfill Eyeglass Orders Without Service Interruption 2NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record 2NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record 3NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record 4NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record 5NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record 6
(Date:4/17/2014)... presence of chronic inflammation in benign prostate tissue ... and this association was found even in those ... a study published in Cancer Epidemiology, Biomarkers ... Association for Cancer Research. , An analysis of ... the placebo arm of the Prostate Cancer Prevention ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... of decline over past decade , , MONDAY, Oct. 15 (HealthDay ... across the United States, offering what an expert called a ... a new report, cancer death rates fell by 2.1 percent ... 1.1 percent annual decline recorded between 1993 and 2003. , ...
... 15, 2007 Post-hoc and other analyses of secondary ... Shire plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative ... LIALDA in patients with mild to moderate ulcerative colitis. ... III, open-label 12-14 month extension study, are being presented ...
... LOGAN, Utah, Oct. 15 Facet Solutions, Inc. ... on the first cohort of,patients to receive its ... these patients at one year include a significant,decline ... function; and no,post-operative complications. Additionally, the first patient ...
... Patients with obstructive sleep apnea (OSA) who also ... continuous positive airway pressure (CPAP) relieves them of symptoms ... October 15 issue of the Journal of Clinical Sleep ... Sleep Center at Universitys Community Hospital in Tampa, Fla., ...
... schedules now routine and,the initial excitement over, lunches will ... a good time to re-evaluate menus and discuss healthier,choices ... The following are suggestions from the experts at ... nutritional impact. Add a,handful of trail mix and fresh ...
... have on average a 71 percent lower chance of ... lowest-rated hospitals across 18 procedures and conditions analyzed in ... issued today by HealthGrades, the healthcare ratings company. The ... of care between the highest-performing hospitals and all others, ...
Cached Medicine News:Health News:U.S. Cancer Death Rate Continues to Fall 2Health News:U.S. Cancer Death Rate Continues to Fall 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 4Health News:Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:Mortality rates 71 percent lower at top-rated hospitals: HealthGrades 2008 hospital-quality study 2Health News:Mortality rates 71 percent lower at top-rated hospitals: HealthGrades 2008 hospital-quality study 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: